Publicaciones en colaboración con investigadoras/es de Instituto de Salud Carlos III (15)

2017

  1. Decrease of invasive pneumococcal disease (IPD) in adults after introduction of pneumococcal 13-valent conjugate vaccine in Spain

    PLoS ONE, Vol. 12, Núm. 4

2014

  1. Spread of streptococcus pneumoniae serotype 8-st63 multidrug-resistant recombinant clone, Spain

    Emerging Infectious Diseases, Vol. 20, Núm. 11, pp. 1848-1856

2012

  1. Prognosis of hospitalized patients with 2009 H1N1 influenza in Spain: Influence of neuraminidase inhibitors

    Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 7, pp. 1739-1745

2009

  1. Changes in fluoroquinolone-resistant Streptococcus pneumoniae after 7-valent conjugate vaccination, Spain

    Emerging Infectious Diseases, Vol. 15, Núm. 6, pp. 905-911

2007

  1. Recomendaciones para la selección de antimicrobianos en el estudio de la sensibilidad in vitro con sistemas automáticos y semiautomáticos

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 25, Núm. 6, pp. 394-400

2006

  1. Combinations of PBPs and MurM protein variants in early and contemporary high-level penicillin-resistant Streptococcus pneumoniae isolates in Spain

    Journal of Antimicrobial Chemotherapy, Vol. 57, Núm. 5, pp. 983-986

2005

  1. Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain

    Antimicrobial Agents and Chemotherapy, Vol. 49, Núm. 5, pp. 1965-1972

  2. Molecular epidemiology of HTLV-2 infection among intravenous drug users in Spain

    Journal of Clinical Virology, Vol. 33, Núm. 1, pp. 65-70

2004

  1. Fluoroquinolone resistance in penicillin-resistant Streptococcus pneumoniae Clones, Spain

    Emerging Infectious Diseases, Vol. 10, Núm. 10, pp. 1751-1759

  2. HIV-2 and HTLV-I/II infections in Spain

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 22, Núm. 3, pp. 177-182

2002

  1. Activity of six quinolones against 226 recent clinical isolates of Streptococcus pyogenes with reduced susceptibility to ciprofloxacin [3]

    Journal of Antimicrobial Chemotherapy

1996

  1. Epidemiology of HIV-2 infection in Spain

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 15, Núm. 5, pp. 383-388

  2. Informe sobre resistencia microbiana: ¿qué hacer?

    Medicina Clinica

1993

  1. HTLV‐I and HTLV‐II Infections in Spain

    Vox Sanguinis

  2. Htlv-i/ii infections in spain

    International Journal of Epidemiology, Vol. 22, Núm. 4, pp. 716-719